GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

zagotenemab   Click here for help

GtoPdb Ligand ID: 10471

Synonyms: LY-3303560 | LY3303560
Compound class: Antibody
Comment: LY3303560 is a monoclonal antibody that selectively targets tau protein aggregates [1]. It is being developed by Eli Lilly for potential to treat Alzheimer's disease. The primary epitope for LY3303560 is located in the N-terminal region of tau.
No information available.
Summary of Clinical Use Click here for help
LY3303560 has progressed to Phase 2 clinical evaluation in patients with early symptomatic Alzhheimer's disease. Click here to link to ClinicalTrials.gov's full list of LY3303560 studies.